Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
International Centre For Genetic Engineering And Biotechnology has 2 pending office actions in the Biotechnology & Pharmaceuticals area. These actions are assigned to 2 distinct examiners and 2 distinct art units. This distribution reflects a spread across different technical units within the patent office.
KONOPKA, CATHERINE ANNE is the busiest examiner for the portfolio, responsible for 1 pending office action. With 2 distinct examiners and 2 distinct art units, the company's current applications are being reviewed by multiple specialized examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 1 | 43.2% | +67.7% |
| KONOPKA, CATHERINE ANNE | 1 | 57.5% | +66.2% |
| ZAHORIK, AMANDA MARY | 1 | 58.3% | +49.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267223 | TREATMENT OF CANCER ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | KONOPKA, CATHERINE ANNE | — |
| 18266387 | TREATMENT OF DISEASES ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | ZAHORIK, AMANDA MARY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18339842 | TREATMENT OF HYPERBILIRUBINEMIA | SINGH, ANOOP KUMAR | — |
| 18267223 | TREATMENT OF CANCER ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | KONOPKA, CATHERINE ANNE | — |
| 18266387 | TREATMENT OF DISEASES ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | ZAHORIK, AMANDA MARY | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1635 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18339842 | TREATMENT OF HYPERBILIRUBINEMIA | SINGH, ANOOP KUMAR | 1632 | §112DP | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18267223 | TREATMENT OF CANCER ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | KONOPKA, CATHERINE ANNE | 1635 | §102§112Other | Non-Final OA | — | Pending | Jun 14, 2023 |
| 18266387 | TREATMENT OF DISEASES ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES | ZAHORIK, AMANDA MARY | 1636 | §103§112 | Non-Final OA | — | Pending | Jun 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInternational Centre For Genetic Engineering And Biotechnology has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Anoop Kumar Singh has the most, with 1 of International Centre For Genetic Engineering And Biotechnology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
